MSB 3.21% $1.13 mesoblast limited

Something went wrong I will try again Does this cover your...

  1. 7,922 Posts.
    lightbulb Created with Sketch. 627
    Something went wrong I will try again

    Does this cover your doubts?
    Specific use of proceeds includes:
    • The private placement will provide financial strength for operational and regulatory initiatives across multiple products as the company undertakes important late-stage meetings with the United States Food & Drug Administration (FDA) in the second and third quarters of this calendar year.
    • Investment in commercial supply of remestemcel-L ahead of potential approval for graft
    versus host disease in children and in optimized manufacturing for larger market opportunities.
    • Advancing manufacturing and development of rexlemestrocel-L platform to meet commercial objectives for chronic heart failure and chronic low back pain due to degenerative disc disease following the recent completion of Phase 3 trials in these indications.
    • Working capital and general corporate purposes.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.